Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Biomarkers in Renal Transplant Recipients at Higher Risk of Acute Rejection

NCT04266613 is registered in ClinicalTrials.gov with Transplant Genomics, Inc. as lead sponsor.

NCT NCT04266613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04266613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Biomarkers in Renal Transplant Recipients at Higher Risk of Acute Rejection
Lead sponsor
Transplant Genomics, Inc.
Phase
Observational
Overall status
Terminated
Start date
February 20, 2020
Completion date
June 23, 2021
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant rejection